We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$215M
AUM Growth
+$5.12M
Cap. Flow
-$12.1M
Cap. Flow %
-5.65%
Top 10 Hldgs %
32.15%
Holding
71
New
17
Increased
13
Reduced
23
Closed
12

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$5.41M
2
RVTY icon
Revvity
RVTY
+$4.91M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.67M
4
HCA icon
HCA Healthcare
HCA
+$4.38M
5
ABT icon
Abbott
ABT
+$4.32M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$9.29M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.42M
3
GILD icon
Gilead Sciences
GILD
+$5.73M
4
AZN icon
AstraZeneca
AZN
+$4.22M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 88.35%
2 Financials 3.26%
3 Energy 1.24%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
51
DELISTED
Sage Therapeutics
SAGE
$1.42M 0.66%
20,000
– –
KITE
52
DELISTED
Kite Pharma, Inc.
KITE
$1.41M 0.66%
18,000
– –
CLVS
53
DELISTED
Clovis Oncology, Inc.
CLVS
$1.27M 0.59%
20,000
+5,000
+33% +$304K
BLUE
54
DELISTED
bluebird bio
BLUE
$1.26M 0.59%
1,073
-85
-7% -$86.7K
PBYI icon
55
Puma Biotechnology
PBYI
$449M
$1.12M 0.52%
30,000
– –
NBIX icon
56
Neurocrine Biosciences
NBIX
$16.8B
$1.08M 0.5%
25,000
– –
SGEN
57
DELISTED
Seagen Inc. Common Stock
SGEN
$943K 0.44%
+15,000
New +$936K
MOH icon
58
Molina Healthcare
MOH
$10.4B
$912K 0.42%
20,000
-70,000
-78% -$3.66M
KND
59
DELISTED
Kindred Healthcare
KND
$812K 0.38%
+97,215
New +$761K
EW icon
60
Edwards Lifesciences
EW
$53B
– –
-45,000
Closed -$1.41M
GILD icon
61
Gilead Sciences
GILD
$165B
– –
-80,000
Closed -$5.73M
HOLX
62
DELISTED
Hologic
HOLX
– –
-40,000
Closed -$1.6M
HSIC icon
63
Henry Schein
HSIC
$9.82B
– –
-50,750
Closed -$3.02M
IBB icon
64
iShares Biotechnology ETF
IBB
$9.82B
– –
-105,000
Closed -$9.29M
IDXX icon
65
Idexx Laboratories
IDXX
$46.9B
– –
-20,000
Closed -$2.35M
JNJ icon
66
Johnson & Johnson
JNJ
$631B
– –
-35,000
Closed -$4.03M
REGN icon
67
Regeneron Pharmaceuticals
REGN
$83.2B
– –
-17,500
Closed -$6.42M
XRAY icon
68
Dentsply Sirona
XRAY
$2.32B
– –
-40,000
Closed -$2.31M
WMGI
69
DELISTED
Wright Medical Group Inc
WMGI
– –
-70,000
Closed -$1.61M
VWR
70
DELISTED
VWR Corporation
VWR
– –
-110,000
Closed -$2.75M
WOOF
71
DELISTED
VCA Inc.
WOOF
– –
-30,000
Closed -$2.06M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q1 2017 Portfolio in Review

As of Q1 2017, Sivik Global Healthcare held 71 positions worth $215M, up 2.4% from $210M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Sivik Global Healthcare withdrew a net $12.1M in Q1 2017, closing 12 positions and reducing 23 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $9.29M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 83% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Baxter International worth $5.71M.

  • Sivik Global Healthcare's largest Q1 2017 buy was Baxter International: 110,000 shares worth $5.71M.
  • Sivik Global Healthcare added most to Eli Lilly in Q1 2017, an estimated $4M increase.
  • Sivik Global Healthcare's biggest Q1 2017 reduction was AstraZeneca, cutting an estimated $4.22M.
  • Sivik Global Healthcare fully exited iShares Biotechnology ETF in Q1 2017, selling an estimated $9.29M.
  • Sivik Global Healthcare's ten largest holdings make up 32% of its $215M portfolio in Q1 2017.
  • Sivik Global Healthcare opened 17 new positions and closed 12 in Q1 2017.
  • Sivik Global Healthcare's portfolio value rose 2.4% quarter-over-quarter to $215M.

Based on Sivik Global Healthcare's 13F filing for Q1 2017, filed 11 May 2017.